From January 6th to 9th, local time in the United States, the International Consumer Electronics Show (CES) opened at the Las Vegas Convention Center. As the most anticipated technology event at the beginning of each year, CES has become a “barometer” for understanding future technological and industrial development. More than 4,100 exhibitors gathered to showcase their latest technological achievements. This year’s CES presented a significant trend: AI is being deeply integrated into various application scenarios in the real world.
Making its debut at CES: Eieling Technology’s professional medical solutions win over many
At this year’s CES, Eieling Technology showcased its innovative achievements. Liverscan® and FattaLab®, with their unique patented technologies and outstanding detection performance, attracted not only experts and scholars from the global healthcare field and potential partners, but also generated strong interest from internet medical companies, digital health platforms, and companies involved in large-scale artificial intelligence models. Several institutions engaged in preliminary discussions with us on-site regarding technology integration, ecosystem cooperation, and future investment and financing directions, jointly exploring an innovative model of “intelligent hardware + data services + health management.”
Eieling Technology’s core product, Liverscan® quantitative shear wave ultrasound liver measurement instrument, provides highly accurate detection technology and superior cost-effectiveness for clinical and primary care screening, helping users to timely detect hidden liver problems and empowering subsequent liver disease diagnosis and treatment. This device features a new generation of exclusive patented TE technology, based on real-time B-mode ultrasound imaging for precise positioning, effectively supporting healthcare professionals in achieving accurate assessment of liver fibrosis and fatty liver. Liverscan® is suitable for various settings, including hepatology, gastroenterology, general medicine, endocrinology, MMC centers, and health management centers. While meeting the clinical testing needs of the target population, it reduces equipment and labor costs by approximately 50%.
Making its debut at CES, the lightweight FattaLab® smart system for assessing fatty liver disease immediately became a focal point. Weighing only 120 grams, FattaLab® is compact and portable, freeing users from the constraints of traditional cables and large equipment, enabling flexible testing anytime, anywhere. It utilizes the AIFF human liver fat detection algorithm, completing quantitative measurement and reporting of liver fat in just 10 seconds, even for individuals with abdominal obesity. AI-guided liver region identification provides users with an automated and intelligent testing experience, expanding the application scenarios for fatty liver detection. In the future, everyone will be able to non-invasively track their liver fat changes regularly in their daily lives and continuously assess their health indicators.
Live Report: FattaLab® receives professional recognition, ushering in a new era of fatty liver disease detection
FattaLab®, winner of the 2026 CES Digital Health Innovation Award, impressed many international visitors. Previously, detecting fatty liver disease often involved complex and time-consuming procedures. This inconvenience made long-term, continuous monitoring difficult and posed obstacles to patients’ daily health management. FattaLab® combines medical-grade accuracy with a consumer-friendly experience, effectively filling a market gap and breaking down the barriers between home testing and professional medical care, truly bringing professional-level health management into everyday life.
Experts and scholars from hospitals, clinics, and other institutions highly praised the products exhibited by Yiling and engaged in in-depth discussions with the team regarding the cutting-edge innovative technologies of Liverscan® and FattaLab®. Many clients shared their insights and suggestions on technology development trends and product application value based on their respective fields.
Technology Empowerment: Making liver health more accessible.
This exhibition marks another significant exposure for Eieling Technology on the global stage. Experts, physicians, and scholars from the United States, Southeast Asia, and other parts of the world came specifically to exchange ideas and discuss collaborations. The fact that FattaLab® won the 2026 CES Digital Health Innovation Award is strong evidence of our continued dedication to innovation in this field. Eieling Technology is committed to leveraging continuous technological innovation to adapt to evolving trends and transform academic achievements into solutions that benefit a wider population. Whether in clinical settings, primary healthcare institutions, clinics, or home environments, our solutions empower users to monitor their health status, scientifically predict potential risks, and make liver health visible, measurable, and manageable.